Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
Conditions: All Cause Mortality; Cardiovascular Diseases; Invasive Cancer; Liver Cirrhosis; Type 2 Diabetes; Depression; Dementia; Injury Traumatic; Tuberculosis; Infections Interventions: Behavioral: Moderate Alcohol Drinking Pattern; Behavioral: Abstention Sponsors: Clinica Universidad de Navarra, Universidad de Navarra Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Manual Therapy in Metabolic Liver Disease
Conditions: NAFLD, Non-alcoholic Fatty Liver Disease Interventions: Procedure: liver treatment protocol Sponsors: University of Seville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
Conditions: Liver Diseases Interventions: Procedure: Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement Sponsors: Methodist Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
A Research Study on Etavopivat in Participants With and Without Liver Disease
Conditions: Liver Diseases Interventions: Drug: Etavopivat Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Conditions: Obesity; Nonalcoholic Fatty Liver; Diabetes Type 2; Healthy Interventions: Other: Dietary consultation weight loss intervention Sponsors: Bettina Mittendorfer; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients
Conditions: Colorectal Cancer Metastatic Interventions: Procedure: 166Holmium TARE; Drug: Cetuximab; Drug: Panitumumab; Drug: 5-Fluorouracil; Drug: Bevacizumab; Drug: Capecitabine Sponsors: Gruppo Oncologico del Nord-Ovest Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Parenchymal Sparing Hepatectomy in Post-chemotherapy Liver Atrophy
Conditions: Colorectal Cancer Stage IV Interventions: Procedure: Hepatectomy Sponsors: Azienda Ospedaliero Universitaria Maggiore della Carita Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Impact of " No-touch " Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Conditions: Liver Transplantation; No-touch Technique; Hepatocellular Carcinoma Interventions: Procedure: Liver transplantation with " No-touch " technique Sponsors: Zhejiang University; Shulan (Hangzhou) Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
Conditions: Liver Transplantation; Hepatocellular Carcinoma; Alpha-Fetoprotein; Protein Induced by Vitamin K Absence or Antagonist-II Sponsors: Zhejiang University; Shulan (Hangzhou) Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Risk Factors and Impact MASLD in Patients With IBD
Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease Interventions: Device: FibroScan Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant.
Conditions: Cirrhosis Interventions: Diagnostic Test: MRI; Biological: Blood sampling Sponsors: Centre Hospitalier Universitaire de Besancon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models
Conditions: Cirrhosis Sponsors: Juan Kang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
A Multicenter, Retrospective Clinical Study on the Clinical Characteristics of Metabolic Associated Fatty Liver Disease
Conditions: Metabolic Associated Fatty Liver Disease; Clinical Features Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs
Conditions: Hepatocellular Carcinoma Interventions: Diagnostic Test: General Evaluation Score (GES) Sponsors: Egyptian Liver Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
Conditions: Fontan Circulation Interventions: Drug: Sildenafil 10mg oral tablet (participants (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
